Is a complete LON/HEMO research report available?

Question

Accepted Answer

No complete published report is available for lon/HEMO (LON/HEMO) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap	34.2M
Net income (ttm)	-9.8M
EPS (ttm)	-GBX 2.20
Shares out	6.8M
Volume	0
Beta	1.49

Metric	Value
Country	United Kingdom
Country code	UK
Employees	16
Employees Change	-1%
Employees Change Percent	-5.88
Enterprise value	GBX 34.5M
Exchange	London Stock Exchange
Financial currency	GBP
First seen	2026-05-10
Industry	Biotechnology
Isin	GB00BQVXM815
Last refreshed	2026-09-09
Market cap	GBX 34.2M
Price	GBX 468
Price currency	GBX
Sector	Healthcare
Sector PE	21.4
Sector PE Fwd	13.66
Sic	2836
Symbol	lon/HEMO
Website	https://hemogenyx.com

Metric	Value
Earnings Yield	-28.56%
FCF yield	-10.1%
P/B ratio	29.86x

Metric	Value
Net Income	GBX -9.8M
Net Income Growth Years	0%
Profit Per Employee	GBX -610,023
ROA	-103.9
Roa5y	-60.96
ROCE	-257.7
ROE	-977.7
Roe5y	-338.5
ROIC	-131.6

Metric	Value
Cagr1y	-38.34%
Cagr3y	-7.46%
Cagr5y	-10.63%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth Years	0x

LON/HEMO (LON/HEMO)

Price

Financial snapshot

Fair-value bridge

Latest news · LON/HEMO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LON/HEMO indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on LON/HEMO

Frequently asked questions

Metric	Value
Assets	GBX 4.2M
Cash	GBX 1.6M
Current Assets	GBX 2M
Current Liabilities	GBX 1.5M
Debt	GBX 2M
Debt Equity	GBX 1.75
Debt FCF	GBX -0.58
Equity	GBX 1.1M
Interest Coverage	-30.38
Liabilities	GBX 3M
Long Term Assets	GBX 2.1M
Long Term Liabilities	GBX 1.6M
Net Cash	GBX -417,816
Net Cash By Market Cap	GBX -1.22
Net Debt Equity	GBX 0.37
Tangible Book Value	GBX 1M
Tangible Book Value Per Share	GBX 0.17
WACC	12.24

Metric	Value
Current ratio	1.38
Net Working Capital	GBX -579,139
Quick ratio	1.09
Working Capital	GBX 564,875

Metric	Value
1Y total return	-38.32%
200-day SMA	758.4
3Y total return	-20.76%
50-day SMA	667.4
50-day SMA vs 200-day SMA	50under200
5Y total return	-42.99%
All Time High	6,155
All Time High Change	-92.4%
All Time High Date	2020-08-26
All Time Low	124
All Time Low Change	277.02%
All Time Low Date	2025-07-15
ATR	56.38
Beta	1.49
Beta1y	0.04
Beta2y	-0.02
Ch YTD	-18.27
High	510
High52	1,800
High52 Date	2025-09-17
High52ch	-74.03%
Low	460
Low52	356
Low52 Date	2025-12-05
Low52ch	31.32%
Ma50ch	-29.95%
Price vs 200-day SMA	-38.36%
RSI	28.17
RSI Monthly	45.47
RSI Weekly	33.03
Sharpe ratio	0.05x
Sharpe Ratio3y	0.39x
Sharpe Ratio5y	0.33x
Sortino ratio	0.13
Sortino Ratio3y	0.76
Sortino Ratio5y	0.64
Total Return	-34.57%
Tr YTD	-18.27
Tr1m	-26.38%
Tr1w	-17.26%
Tr3m	-35.25%

Metric	Value
Float	5,264,892%
Net Borrowing	-632,575
Shares Insiders	18.79%
Shares Institutions	62.21%
Shares Out	6,799,961
Shares Qo Q	51.29%
Shares Yo Y	34.57%

Metric	Value
Adjusted FCF	GBX -3.5M
Adjusted OCF	-3,511,144
Average Volume	20,347.5x
Bv Per Share	0.2
CAPEX	GBX -3,921
Ch1m	-26.38
Ch1w	-17.26
Ch1y	-38.32
Ch3m	-35.25
Ch3y	-20.76
Ch5y	-42.99
Ch6m	-55.48
Change	-6.97%
Change From Open	-8.33
Close	502.5
Days Gap	1.49
Depreciation Amortization	188,926
Earnings Date	2026-09-25
EBIT	GBX -7M
EBITDA	GBX -6.8M
EPS	GBX -2.2
F Score	2
FCF	GBX -3.5M
FCF EV Yield	-9.99x
FCF Per Share	GBX -0.51
Financing CF	4,889,828
Fiscal Year End	December
Founded	2,013
Investing CF	-6,797
Is Primary Listing	1
Last Earnings Date	2025-09-26
Last Report Date	2025-12-31
Last Split Date	2024-12-13
Last Split Type	Reverse
Ma150	800.8
Ma150ch	-41.62%
Ma20	581.4
Ma20ch	-19.59%
Net CF	1,427,165
Next Earnings Date	2026-09-25
Open	510
Position In Range	15
Ppne	1,802,639
Price Date	2026-09-08
Ptbv Ratio	33.72
Relative Volume	4.58x
Share Based Comp	63,152
Tr6m	-55.48%
Volume	0